{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:05:41Z","timestamp":1787994341830,"version":"build-2784847793"},"reference-count":71,"publisher":"Cold Spring Harbor Laboratory","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cold Spring Harb Mol Case Stud"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:p>\n                    As in other brain tumors, multiple recurrences after complete resection and irradiation of supratentorial ependymoma are common and frequently result in patient death. This standard-of-care treatment was established in the pregenomic era without the ability to evaluate the effect that mutagenic therapies may exert on tumor evolution and in promoting resistance, recurrence, and death. We seized a rare opportunity to characterize treatment effects and the evolution of a single patient's ependymoma across four recurrences after different therapies. A combination of high-depth whole-genome and exome-based DNA sequencing of germline and tumor specimens, RNA sequencing of tumor specimens, and advanced computational analyses were used. Treatment with radiation and chemotherapies resulted in a substantial increase in mutational burden and diversification of the tumor subclonal architecture without eradication of the founding clone. Notable somatic alterations included a\n                    <jats:italic>MEN1<\/jats:italic>\n                    driver, several epigenetic modifiers, and therapy-induced mutations that impacted multiple other cancer-relevant pathways and altered the neoantigen landscape. These genomic data provided new mechanistic insights into the genesis of ependymoma and pathways of resistance. They also revealed that radiation and chemotherapy were significant forces in shaping the increased subclonal complexity of each tumor recurrence while also failing to eradicate the founding clone. This raises the question of whether standard-of-care treatments have similar consequences in other patients with ependymoma and other types of brain tumors. If so, the perspective obtained by real-time genomic characterization of a tumor may be essential for making effective patient-specific and adaptive clinical decisions.\n                  <\/jats:p>","DOI":"10.1101\/mcs.a002444","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T20:41:17Z","timestamp":1518554477000},"page":"a002444","source":"Crossref","is-referenced-by-count":18,"title":["Resistance-promoting effects of ependymoma treatment revealed through genomic analysis of multiple recurrences in a single patient"],"prefix":"10.1101","volume":"4","author":[{"given":"Christopher A.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonika","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiandao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin P.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine R.","family":"Mardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"246","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"2021112506144632000_4.2.a002444.1","doi-asserted-by":"crossref","first-page":"13476","DOI":"10.18632\/oncotarget.14564","article-title":"RYK promotes the stemness of glioblastoma cells via the WNT\/\u03b2-catenin pathway","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"2021112506144632000_4.2.a002444.2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF03346599","article-title":"Intracranial ependymoma associated with multiple endocrine neoplasia type 1","volume":"33","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"2021112506144632000_4.2.a002444.3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ccell.2015.04.015","article-title":"Defining the molecular landscape of ependymomas","volume":"27","year":"2015","journal-title":"Cancer Cell"},{"key":"2021112506144632000_4.2.a002444.4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1232044"},{"key":"2021112506144632000_4.2.a002444.5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12605"},{"key":"2021112506144632000_4.2.a002444.6","first-page":"2725","article-title":"Multifaceted resistance of gliomas to temozolomide","volume":"8","year":"2002","journal-title":"Clin Cancer Res"},{"key":"2021112506144632000_4.2.a002444.7","first-page":"545","article-title":"Formation of DNA adducts and induction of lacI mutations in Big Blue Rat-2 cells treated with temozolomide: implications for the treatment of low-grade adult and pediatric brain tumors","volume":"12","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2021112506144632000_4.2.a002444.8","doi-asserted-by":"publisher","DOI":"10.1038\/nature14216"},{"key":"2021112506144632000_4.2.a002444.9","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-008-9089-1"},{"key":"2021112506144632000_4.2.a002444.10","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00335-09"},{"key":"2021112506144632000_4.2.a002444.11","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1363"},{"key":"2021112506144632000_4.2.a002444.12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2860"},{"key":"2021112506144632000_4.2.a002444.13","doi-asserted-by":"crossref","first-page":"18429","DOI":"10.18632\/oncotarget.4384","article-title":"miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2","volume":"6","year":"2015","journal-title":"Oncotarget"},{"key":"2021112506144632000_4.2.a002444.14","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2514"},{"key":"2021112506144632000_4.2.a002444.15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1017192108"},{"key":"2021112506144632000_4.2.a002444.16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11060-015-1891-1","article-title":"CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma","volume":"125","year":"2015","journal-title":"J Neurooncol"},{"key":"2021112506144632000_4.2.a002444.17","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1093\/annonc\/mdx517","article-title":"ClonEvol: clonal ordering and visualization in cancer sequencing","volume":"28","year":"2017","journal-title":"Ann Oncol."},{"key":"2021112506144632000_4.2.a002444.18","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1016\/S1470-2045(16)30553-8","article-title":"MNX1: a novel prostate cancer oncogene","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"key":"2021112506144632000_4.2.a002444.19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/B978-0-12-802997-8.00025-6","article-title":"Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options","volume":"134","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"2021112506144632000_4.2.a002444.20","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.spinee.2013.02.066","article-title":"Tanycytic ependymoma of the filum terminale associated with multiple endocrine neoplasia type 1: first reported case","volume":"13","year":"2013","journal-title":"Spine J"},{"key":"2021112506144632000_4.2.a002444.21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205822"},{"key":"2021112506144632000_4.2.a002444.22","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3892\/or.2017.5344","article-title":"Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells","volume":"37","year":"2017","journal-title":"Oncol Rep"},{"key":"2021112506144632000_4.2.a002444.23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004274"},{"key":"2021112506144632000_4.2.a002444.24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cels.2015.08.015","article-title":"Optimizing cancer genome sequencing and analysis","volume":"1","year":"2015","journal-title":"Cell Syst"},{"key":"2021112506144632000_4.2.a002444.25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3158"},{"key":"2021112506144632000_4.2.a002444.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043331"},{"key":"2021112506144632000_4.2.a002444.27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13073-016-0264-5","article-title":"pVAC-Seq: a genome-guided in silico approach to identifying tumor neoantigens","volume":"8","year":"2016","journal-title":"Genome Med"},{"key":"2021112506144632000_4.2.a002444.28","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-31-67"},{"key":"2021112506144632000_4.2.a002444.29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009472"},{"key":"2021112506144632000_4.2.a002444.30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0503484102"},{"key":"2021112506144632000_4.2.a002444.31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2169\/internalmedicine.35.285","article-title":"Multiple endocrine neoplasia type 1 associated with spinal ependymoma","volume":"35","year":"1996","journal-title":"Intern Med"},{"key":"2021112506144632000_4.2.a002444.32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejca.2016.10.013","article-title":"Current therapy and the evolving molecular landscape of paediatric ependymoma","volume":"70","year":"2017","journal-title":"Eur J Cancer"},{"key":"2021112506144632000_4.2.a002444.33","doi-asserted-by":"publisher","DOI":"10.1101\/gr.129684.111"},{"key":"2021112506144632000_4.2.a002444.34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4197"},{"key":"2021112506144632000_4.2.a002444.35","doi-asserted-by":"publisher","DOI":"10.1126\/science.1196554"},{"key":"2021112506144632000_4.2.a002444.36","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr665"},{"key":"2021112506144632000_4.2.a002444.37","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1007\/s00586-016-4745-4","article-title":"Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches","volume":"25","year":"2016","journal-title":"Eur Spine J"},{"key":"2021112506144632000_4.2.a002444.38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3340\/jkns.2016.59.2.83","article-title":"The similarities and differences between intracranial and spinal ependymomas: review from a genetic research perspective","volume":"59","year":"2016","journal-title":"J Korean Neurosurg Soc"},{"key":"2021112506144632000_4.2.a002444.39","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"2021112506144632000_4.2.a002444.40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2265.2007.03034.x","article-title":"Evaluation of CDKN2C\/p18, CDKN1B\/p27 and CDKN2B\/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours","volume":"68","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021112506144632000_4.2.a002444.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.06.090"},{"key":"2021112506144632000_4.2.a002444.42","doi-asserted-by":"publisher","DOI":"10.1038\/nature13108"},{"key":"2021112506144632000_4.2.a002444.43","doi-asserted-by":"publisher","DOI":"10.1038\/nature756"},{"key":"2021112506144632000_4.2.a002444.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2013.05.005"},{"key":"2021112506144632000_4.2.a002444.45","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21806"},{"key":"2021112506144632000_4.2.a002444.46","doi-asserted-by":"publisher","DOI":"10.3171\/2008.9.JNS08117"},{"key":"2021112506144632000_4.2.a002444.47","doi-asserted-by":"publisher","DOI":"10.1101\/gr.107524.110"},{"key":"2021112506144632000_4.2.a002444.48","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9357"},{"key":"2021112506144632000_4.2.a002444.49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003665"},{"key":"2021112506144632000_4.2.a002444.50","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/NEN.0000000000000238","article-title":"Alterations in the NF2\/LATS1\/LATS2\/YAP pathway in Schwannomas","volume":"74","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"key":"2021112506144632000_4.2.a002444.51","first-page":"77","article-title":"[Early induction of diabetes in NOD mice by streptozotocin]","volume":"304","year":"1987","journal-title":"CR Acad Sci III"},{"key":"2021112506144632000_4.2.a002444.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.04.002"},{"key":"2021112506144632000_4.2.a002444.53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-016-1643-0","article-title":"The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants","volume":"133","year":"2017","journal-title":"Acta Neuropathol"},{"key":"2021112506144632000_4.2.a002444.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.12.020"},{"key":"2021112506144632000_4.2.a002444.55","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0893-4"},{"key":"2021112506144632000_4.2.a002444.56","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts271"},{"key":"2021112506144632000_4.2.a002444.57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0020051"},{"key":"2021112506144632000_4.2.a002444.58","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.devcel.2016.09.027","article-title":"Rac1-mediated DNA damage and inflammation promote Nf2 tumorigenesis but also limit cell-cycle progression","volume":"39","year":"2016","journal-title":"Dev Cell"},{"key":"2021112506144632000_4.2.a002444.59","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2012.016"},{"key":"2021112506144632000_4.2.a002444.60","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(01)00532-5"},{"key":"2021112506144632000_4.2.a002444.61","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/leu.2016.282","article-title":"Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy","volume":"31","year":"2017","journal-title":"Leukemia"},{"key":"2021112506144632000_4.2.a002444.62","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou162"},{"key":"2021112506144632000_4.2.a002444.63","doi-asserted-by":"publisher","DOI":"10.2174\/1566524014666140414205943"},{"key":"2021112506144632000_4.2.a002444.64","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3221"},{"key":"2021112506144632000_4.2.a002444.65","doi-asserted-by":"publisher","DOI":"10.1186\/gm396"},{"key":"2021112506144632000_4.2.a002444.66","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2016.141"},{"key":"2021112506144632000_4.2.a002444.67","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.382416"},{"key":"2021112506144632000_4.2.a002444.68","doi-asserted-by":"publisher","DOI":"10.1038\/nature14328"},{"key":"2021112506144632000_4.2.a002444.69","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.18632\/oncotarget.7279","article-title":"Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"2021112506144632000_4.2.a002444.70","first-page":"108","article-title":"INTEGRATE: gene fusion discovery using whole genome and transcriptome data","volume":"26","year":"2015","journal-title":"Genome Res"},{"key":"2021112506144632000_4.2.a002444.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2014.08.018"}],"container-title":["Molecular Case Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/mcs.a002444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T01:38:18Z","timestamp":1719797898000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecularcasestudies.cshlp.org\/lookup\/doi\/10.1101\/mcs.a002444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":71,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,4,2]]},"published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1101\/mcs.a002444"],"URL":"https:\/\/doi.org\/10.1101\/mcs.a002444","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/115923","asserted-by":"object"}]},"ISSN":["2373-2865","2373-2873"],"issn-type":[{"value":"2373-2865","type":"print"},{"value":"2373-2873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,13]]}}}